# The Use of Memantine for Prevention of Alzheimer's Disease

> **NCT05063851** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Virginia** · enrollment: 32 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** Memantine Hydrochloride Tablets
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05063851
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-10-11
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05063851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05063851, "The Use of Memantine for Prevention of Alzheimer's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05063851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*